Current profit after tax for the first 2 months of the 2nd half of FY19 is in excess of $1 million.
The estimated income tax benefit of our R&D return is approximately $220,000 and will contribute to the 2nd half FY19 result.
YTD powder sales are 239% greater than FY18 for the same comparable 7 month period. This percentage could have been higher without the ANO production constraints.
Currently have 82T of future XP powder sales orders in the system for March – June
